TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals
- PMID: 19797732
- PMCID: PMC2805730
- DOI: 10.3324/haematol.2009.011536
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individuals
Abstract
Background: The formation of fusion genes plays roles in both oncogenesis and evolution by facilitating the acquisition of novel functions. Here we describe the first example of a human polymorphic in-frame fusion of two unrelated genes associated with a copy number variant.
Design and methods: Array comparative genomic hybridization was used to identify cryptic oncogenic fusion genes. Fusion gene structure and origin was examined using molecular biological and computational methods. Phenotype associations were examined using PopGen cohorts.
Results: Targeted array comparative genomic hybridization to identify cryptic oncogenic fusion genes in patients with atypical myeloproliferative neoplasms identified a 111 kb amplification with breakpoints within the TRK-fused gene (TFG, a target of translocations in lymphoma and thyroid tumors) and G-protein-coupled receptor 128 (GPR128) resulting in an expressed in-frame TFG-GPR128 fusion transcript. The fusion gene was also identified in healthy individuals at a frequency of 0.02 (3/120). Normally both genes are in identical orientations with TFG immediately downstream of GPR128. In individuals with a copy number variant amplification, one or two copies of the TFG-GPR128 fusion are found between the two parental genes. The breakpoints share a region of microhomology, and haplotype and microsatellite analysis indicate a single ancestral origin. Analysis of PopGen cohorts showed no obvious phenotype association. An in silico search of EST databases found no other copy number variant amplification-associated fusion transcripts, suggesting that this is an uncommon event. Conclusions The finding of a polymorphic gene fusion in healthy individuals adds another layer to the complexity of human genome variation and emphasizes the importance of careful discrimination of oncogenic changes found in tumor samples from non-pathogenic normal variation.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2805730/bin/9520.fig1.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2805730/bin/9520.fig2.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2805730/bin/9520.fig3.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2805730/bin/9520.fig4.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2805730/bin/9520.fig5.gif)
Similar articles
-
Diversity of genomic breakpoints in TFG-ALK translocations in anaplastic large cell lymphomas: identification of a new TFG-ALK(XL) chimeric gene with transforming activity.Am J Pathol. 2002 Apr;160(4):1487-94. doi: 10.1016/S0002-9440(10)62574-6. Am J Pathol. 2002. PMID: 11943732 Free PMC article.
-
Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the Diagnosis of Bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal Bone Cysts.Arch Pathol Lab Med. 2021 Jul 1;145(7):851-863. doi: 10.5858/arpa.2020-0336-OA. Arch Pathol Lab Med. 2021. PMID: 33147323
-
Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.Int J Cancer. 2002 Jun 1;99(4):560-7. doi: 10.1002/ijc.10404. Int J Cancer. 2002. PMID: 11992546
-
Fusion genes and chromosome translocations in the common epithelial cancers.J Pathol. 2010 Jan;220(2):244-54. doi: 10.1002/path.2632. J Pathol. 2010. PMID: 19921709 Review.
-
Molecular strategies for detecting chromosomal translocations in soft tissue tumors (review).Int J Mol Med. 2014 Jun;33(6):1379-91. doi: 10.3892/ijmm.2014.1726. Epub 2014 Apr 4. Int J Mol Med. 2014. PMID: 24714847 Free PMC article. Review.
Cited by
-
Identification of a rare copy number polymorphic gain at 3q12.2 with candidate genes for familial endometriosis.Rev Bras Ginecol Obstet. 2024 Mar 15;46:e-rbgo12. doi: 10.61622/rbgo/2024CR12. eCollection 2024. Rev Bras Ginecol Obstet. 2024. PMID: 38765507 Free PMC article.
-
Discovery of a polymorphic gene fusion via bottom-up chimeric RNA prediction.Nucleic Acids Res. 2024 May 8;52(8):4409-4421. doi: 10.1093/nar/gkae258. Nucleic Acids Res. 2024. PMID: 38587197 Free PMC article.
-
CTAT-LR-fusion: accurate fusion transcript identification from long and short read isoform sequencing at bulk or single cell resolution.bioRxiv [Preprint]. 2024 Feb 28:2024.02.24.581862. doi: 10.1101/2024.02.24.581862. bioRxiv. 2024. PMID: 38464114 Free PMC article. Preprint.
-
CTNNBIP1-CLSTN1 functions as a housekeeping chimeric RNA and regulates cell proliferation through SERPINE2.Cell Death Discov. 2023 Oct 7;9(1):369. doi: 10.1038/s41420-023-01668-8. Cell Death Discov. 2023. PMID: 37805599 Free PMC article.
-
CTNNBIP1-CLSTN1 Functions as a Housekeeping Chimeric RNA, and Regulates Cell Proliferation through SERPINE2.Res Sq [Preprint]. 2023 Jul 17:rs.3.rs-3112431. doi: 10.21203/rs.3.rs-3112431/v1. Res Sq. 2023. Update in: Cell Death Discov. 2023 Oct 7;9(1):369. doi: 10.1038/s41420-023-01668-8. PMID: 37503100 Free PMC article. Updated. Preprint.
References
-
- Eichler EE. Recent duplication, domain accretion and the dynamic mutation of the human genome. Trends Genet. 2001;17(11):661–9. - PubMed
-
- Cools J, DeAngelo DJ, Gotlib J, Stover EH, Legare RD, Cortes J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348(13):1201–14. - PubMed
-
- Graux C, Cools J, Melotte C, Quentmeier H, Ferrando A, Levine R, et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia. Nat Genet. 2004;36(10):1084–9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials